Vymada 100 mg (Sacubitril/Valsartan) Quantity:28 Tablet/s Avoid in pregnancy (first trimester)

Avoid in pregnancy (first trimester) unless clinically justified—use only under medical supervision

Active Ingredient Ivermectin USP (6 mg) Therapeutic Class Antiparasitic / Anthelmintic Agent Primary Manufacturer Healing Pharma Concentration Strength 6mg standard mid-potency profile per tablet Administration Route Oral consumption (Swallowed whole on an empty stomach) Packaging Format Secure

Mild back comfort changes or temporary muscle relaxation that clears up naturally

On-Demand Rigidity Support: Acts as a highly responsive

Vymada 100 mg (Sacubitril/Valsartan) Quantity:28 Tablet/s Avoid in pregnancy (first trimester)Product Overview Vymada 100 mg is a prescription medication that combines two active pharmaceutical ingredients, sacubitril and valsartan, in a single tablet. The product is manufactured by Novartis India Ltd and is formulated for the management of chronic heart failure in adult patients. Each pack contains either 28 tablets or a 14tablet strip, providing a convenient supply for monthly treatment cycles. The medication is classified under the